Abstract
Purpose
To validate Postnatal Growth and Retinopathy of Prematurity (G-ROP) criteria for Thai infants.
Study design
A retrospective review of infants receiving ROP screening during 2009–2020.
Methods
Baseline characteristics, clinical progression and final ROP outcomes were collected. G-ROP was applied to infants who met at least one of the following 6 criteria: birth weight (BW) below 1051 g, gestational age (GA) under 28 weeks, weight gain (WG) less than 120 g during postnatal day 10–19, WG less than 180 g during day 20–29, WG less than 170 g during day 30–39 and hydrocephalus.
Results
A total of 684 infants (boys, 53.4%) were included. Median (IQR) BW was 1200 (960–1470) grams and median GA was 30 (28–32) weeks. Prevalence of ROP was 26.6%, with 28 (4.1%) having type 1, 19 (2.8%) type 2 and, 135 (19.7%) having other ROP. Treatment was performed in 26 infants (3.8%). Sensitivity of G-ROP to include type 1, 2 or treatment-requiring ROP cases was 100% with 36.9% specificity, excluding 235 (34.4%) cases of unnecessary screening. To adjust for our setting of initial eye examination at 4 weeks’ postnatal date, the last 2 criteria of G-ROP were replaced by the occurrence of grade 3 or 4 intraventricular hemorrhage (IVH). This modified G-ROP criteria yielded 100% sensitivity, 42.5% specificity and excluded 271 (39.6%) cases of unnecessary screening.
Conclusion
G-ROP criteria can be applied to our hospital setting. Occurrence of IVH grade 3 or 4 was proposed as an alternative in modified G-ROP criteria.
Similar content being viewed by others
References
Hellström A, Smith LEH, Dammann O. Retinopathy of prematurity. Lancet. 2013;382:1445–57.
Early Treatment For Retinopathy Of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121:1684–94.
Early Treatment For Retinopathy Of Prematurity Cooperative Group, Good WV, Hardy RJ, Dobson V, Palmer EA, Phelps DL, et al. Final visual acuity results in the early treatment for retinopathy of prematurity study. Arch Ophthalmol. 2010;128:663–71.
Mitchell AJ, Green A, Jeffs DA, Roberson PK. Physiologic effects of retinopathy of prematurity screening examinations. Adv Neonatal Care. 2011;11:291–7.
Obata S, Imamura T, Kakinoki M, Yanagi T, Maruo Y, Ohji M. Systemic adverse events after screening of retinopathy of prematurity with mydriatic. PLoS ONE. 2021;16:e0256878.
Fierson WM, American Academy of Pediatrics Section on Ophthalmology, American Academy of Ophthalmology. American Association for Pediatric Ophthalmology and Strabismus, American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2018;142:e20183061.
Royal College of Paediatrics and Child Health. London:Screening of Retinopathy of Prematurity (ROP)-clinical guideline.http://www.rcpch.ac.uk/resources/screening-retinopathy-prematurity-rop-clinical-guideline Accessed3March2022.
Trinavarat A, Atchaneeyasakul LO, Udompunturak S. Applicability of american and british criteria for screening of the retinopathy of prematurity in Thailand. Jpn J Ophthalmol. 2004;48:50–3.
Gilbert C, Fielder A, Gordillo L, Quinn G, Semiglia R, Visintin P, et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics. 2005;115:e518–25.
Hellstrom A, Perruzzi C, Ju M, Engstrom E, Hard AL, Liu JL, et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A. 2001;98:5804–8.
Hellström A, Engström E, Hård AL, Albertsson-Wikland K, Carlsson B, Niklasson A, et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics. 2003;112:1016–20.
Jensen AK, Ying GS, Huang J, Quinn GE, Binenbaum G. Postnatal serum insulin-like growth factor I and retinopathy of prematurity. Retina. 2017;37:867–72.
Löfqvist C, Andersson E, Sigurdsson J, Engström E, Hård AL, Niklasson A, et al. Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity. Arch Ophthalmol. 2006;124:1711–8.
Hellström A, Hård AL, Engström E, Niklasson A, Andersson E, Smith L, et al. Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening. Pediatrics. 2009;123:e638–45.
Binenbaum G, Ying GS, Quinn GE, Dreiseitl S, Karp K, Roberts RS, et al. A clinical prediction model to stratify retinopathy of prematurity risk using postnatal weight gain. Pediatrics. 2011;127:e607–14.
Binenbaum G, Ying GS, Quinn GE, Huang J, Dreiseitl S, Antigua J, et al. The CHOP postnatal weight gain, birth weight, and gestational age retinopathy of prematurity risk model. Arch Ophthalmol. 2012;130:1560–5.
Eckert GU, Fortes Filho JB, Maia M. A predictive score for retinopathy of prematurity in very low birth weight preterm infants. Eye (Lond). 2012;26:400–6.
Cao JH, Wagner BD, Cerda A, McCourt EA, Palestine A, Enzenauer RW, et al. Colorado retinopathy of prematurity model: a multi-institutional validation study. J AAPOS. 2016;20:220–5.
Binenbaum G, Bell EF, Donohue P, Quinn G, Shaffer J, Tomlinson LA, et al. Development of modified screening criteria for retinopathy of prematurity: primary results from the postnatal growth and retinopathy of prematurity study. JAMA Ophthalmol. 2018;136:1034–40.
Athikarisamy S, Desai S, Patole S, Rao S, Simmer K, Lam GC. The use of postnatal weight gain algorithms to predict severe or type 1 retinopathy of prematurity: a systematic review and meta-analysis. JAMA Netw Open. 2021;4:e2135879.
Binenbaum G, Tomlinson LA, de Alba Campomanes AG, Bell EF, Donohue P, Morrison D, et al. Validation of the postnatal growth and retinopathy of prematurity screening criteria. JAMA Ophthalmol. 2020;138:31–7.
Shiraki A, Fukushima Y, Kawasaki R, Sakaguchi H, Mitsuhashi M, Ineyama H, et al. Retrospective validation of the postnatal growth and retinopathy of prematurity (G-ROP) criteria in a japanese cohort. Am J Ophthalmol. 2019;205:50–3.
Yabas Kiziloglu O, Coskun Y, Akman I. Assessment of the G-ROP study criteria for predicting retinopathy of prematurity: results from a tertiary centre in Turkey. Int Ophthalmol. 2020;40:1647–52.
Wadley S, Recko M, Samson S. Validation of the postnatal growth and retinopathy of prematurity screening criteria. Proc (Bayl Univ Med Cent). 2020;33:546–9.
Ahmed ISH, Aclimandos W, Azad N, Zaheer N, Barry JS, Ambulkar H, et al. The postnatal growth and retinopathy of prematurity model: a multi-institutional validation study. Ophthalmic Epidemiol. 2022;29:296–301.
Caruggi S, Scaramuzzi M, Calevo MG, Priolo E, Sposetti L, Camicione P, et al. Validation of the postnatal growth and retinopathy of prematurity screening criteria: a retrospective italian analysis. Eur J Ophthalmol. 2022;32:1169–73.
Almeida AC, Sandinha T, Azevedo R, Brízido M, Figueiredo M, Coelho C, et al. Retrospective comparison between growth and retinopathy of prematurity model versus WINROP model. Can J Ophthalmol. 2022;57:58–64.
Vinayahalingam N, McDougall J, Ahrens O, Ebneter A. Retrospective validation of the postnatal growth and retinopathy of prematurity (G-ROP) criteria in a swiss cohort. BMC Ophthalmol. 2022;22:19.
Reynolds JD, Dobson V, Quinn GE, Fielder AR, Palmer EA, Saunders RA, et al. Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol. 2002;120:1470–6.
Ballabh P. Intraventricular hemorrhage in premature infants: mechanism of disease. Pediatr Res. 2010;67:1–8.
Acknowledgements
The authors gratefully acknowledge Nutchavadee Vorasan of Siriraj Genomics of the Faculty of Medicine Siriraj Hospital, Mahidol University for her assistance in the use of the REDCap web application. We would like to thank Kevin P Jones for his valuable assistance with English language editing.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
A. Trinavarat, None; N. Najmuangchan, None; S. Ngerncham, None; S. Piampradad, None; P. Nunthanid, None; D. Tatritorn, None; T. Amnartpanich, None; N. Limkongngam, None; T. Praikanarat, None; N. Arjkongharn, None; S. Udompunthurak, None; L. Atchaneeyasakul, None.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Corresponding Author: La-ongsri Atchaneeyasakul
About this article
Cite this article
Trinavarat, A., Najmuangchan, N., Ngerncham, S. et al. Validation of the postnatal growth and retinopathy of prematurity (G-ROP) screening criteria in a Thai cohort. Jpn J Ophthalmol 67, 387–395 (2023). https://doi.org/10.1007/s10384-023-01003-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-023-01003-9